tumor lysis syndrome - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC11043241/ Tumor lysis syndrome following letrozole for locally advanced breast cancer: a case report - PMC Letrozole, an aromatase inhibitor, is used to treat breast cancer in postmenopausal women. Tumor lysis syndrome (TLS) is a complication that can trigger... tumor lysis syndrome https://pmc.ncbi.nlm.nih.gov/articles/PMC12747779/ Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer - PMC Tumor lysis syndrome (TLS) arises from the rapid breakdown of tumor cells during oncological treatment. Although TLS is rarely observed in solid tumors, few... tumor lysis syndrome https://pubmed.ncbi.nlm.nih.gov/37755660/ Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from... This pharmacovigilance study on the FDA Adverse Event Reporting System detected a plausible association between CD20 monoclonal antibodies (but not CD52) and... tumor lysis syndrome https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/Tumor-lysis-syndrome-in-extensive-stage-small-cell/991019167342604721?institution=01DRXU_INST&skipUsageReporting=true&recordUsage=false Tumor lysis syndrome in extensive-stage small-cell lung cancer - Drexel University Tumor lysis syndrome in extensive-stage small-cell lung cancer - Drexel University - Journal article small cell lung cancer tumor lysis syndrome https://consultqd.clevelandclinic.org/study-supports-single-dose-rasburicase-for-tumor-lysis-syndrome Study Supports Single-Dose Rasburicase for Tumor Lysis Syndrome Findings from a Cleveland Clinic-led study suggest that a single, weight-based dose of rasburicase is effective in preventing tumor lysis syndrome in children,... single dose study supports rasburicase tumor https://scholars.duke.edu/publication/789126 Scholars@Duke publication: Control of plasma uric acid in adults at risk for tumor Lysis syndrome:...